Market Introduction
Among patients undergoing orthopedic implant surgery, bacterial infection and infection-induced immune responses have become a life-threatening concern. Biocontamination of conventional biomaterials causes bacterial invasion in injured areas, resulting in postoperative illness. As a result, anti-infection and immune-evasive coatings for orthopedic implants are desperately needed. Orthopedic implants such as screws, plates, nails, and artificial joints have grown in great demand by hospitals for orthopedic surgery.
Moreover, the rise in prevalence of implant-associated infections is expected to bolster the market growth during the forecast period.
As the COVID-19 pandemic continues to unfold, medical device companies are finding difficulties in managing their operations. Many companies offering products for orthopedic implant antibacterial coatings surface treatment have their business operations in the United States and business are adversely being affected by the effects of a widespread outbreak of COVID-19. This has disrupted and restricted company’s ability to distribute products, as well as temporary closures of company’s facilities. Also, to free-up limited space for people being treated for the virus, hospitals have postponed, or cancelled. For instance, as per the British Journal of Surgery published in May 2020 stated that orthopedic procedures would be affected most, with 6.3 million operations cancelled worldwide. Cancelling elective surgeries to reduce exposure to COVID-19 in the hospital and operating rooms into intensive care units is also negatively affecting the growth of the orthopedic implant antibacterial coatings surface treatment market.
Market Overview and Dynamics
The Europe Orthopedic Implant Antibacterial Coatings Surface Treatment market is projected to reach US$ 49,787.7 million by 2028 from US$ 24,906.1 million in 2021; it is anticipated to grow at a CAGR of 10.4% from 2021 to 2028. The orthopedic implant antibacterial coatings surface treatment market is characterized by the presence of various small and big companies. The market players are adopting the strategies such as new product launch, regional expansion, and technological advancements to increase their market share. Rising demand for orthopedic implants due to increasing number of orthopedic incidences and increased prevalence of surgical site infections related with orthopedic implants has encouraged market players to launch new product in orthopedic implant antibacterial coatings surface treatment market. Microbial colonization, infection, and biofilm formation are major complications in the use of implants and are the predominant risk factors in orthopedic implant failure. Through the development of biomaterials and nanotechnology, antimicrobial nanoparticles are becoming promising candidates for implant coatings. Market players are investing in R&D to develop advanced technologies and gain more revenue share by acquiring regulatory approvals and marketing access.
Key Market Segments
In terms of type, the active surface finishing/modifications (ASM) segment accounted for the largest share of the Europe Orthopedic Implant Antibacterial Coatings Surface Treatment market in 2020. Further, based on material type, the metallic coatings segment held the largest market share in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the Orthopedic Implant Antibacterial Coatings Surface Treatment market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are DOT GmbH, Covalon Technologies Ltd., Sciessent LLC, Harland Medical Systems, Inc., Isoflux, Inc., Allvivo Vascular, Inc., aap Implantate AG, BASF SE, and Agienic Inc.
Reasons to Buy Report
- To understand the Europe Orthopedic Implant Antibacterial Coatings Surface Treatment market landscape and identify market segments that are likely to guarantee a strong return
- To comprehend the ever-changing market landscape and stay ahead in competition
- To efficiently plan merger and acquisition, and partnership deals in the Europe Orthopedic Implant Antibacterial Coatings Surface Treatment market by identifying segments with the most promising probable sales
- To make knowledgeable business decisions from perceptive and comprehensive analysis of the market performance of various segments
- To obtain market revenue forecast of the Europe Orthopedic Implant Antibacterial Coatings Surface Treatment market based on various segments for the period 2021–2028
EUROPE ORTHOPEDIC IMPLANT ANTIBACTERIAL COATINGS SURFACE TREATMENT MARKET SEGMENTATION
- Active Surface Finishing/Modifications (ASM)
- Passive Surface Finishing/Modifications (PSM)
- Peri-Operative Antibacterial Local Carriers or Coatings (LCC)
- Metallic Coatings
- Non-Metallic Coatings
By Country
-
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Companies Mentioned
- DOT GmbH
- Covalon Technologies Ltd.
- Harland Medical Systems, Inc.
- aap Implantate AG
- BASF SE
- ARAN BIOMEDICAL
Europe Orthopedic Implant Antibacterial Coatings Surface Treatment Market Strategic Insights
Europe Orthopedic Implant Antibacterial Coatings Surface TreatmentMarket Report Highlights
| Report Attribute | Details |
| Market size in 2021 | US$ 24,906.1 Million |
| Market Size by 2028 | US$ 49,787.7 Million |
| CAGR (2021 - 2028) | 10.4% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
Europe Orthopedic Implant Antibacterial Coatings Surface Treatment Market Country and Regional Insights
